MétaCan
Menu
Back to cohort
Record W4390731794 · doi:10.1016/s0140-6736(23)02356-5

Indomethacin with or without prophylactic pancreatic stent placement to prevent pancreatitis after ERCP: a randomised non-inferiority trial

2024· article· en· W4390731794 on OpenAlexaff
B. Joseph Elmunzer, Lydia D. Foster, José Serrano, Gregory A. Coté, Steven A. Edmundowicz, Sachin Wani, Raj J. Shah, Ji Young Bang, Shyam Varadarajulu, Vikesh K. Singh, Mouen A. Khashab, Richard S. Kwon, James M. Scheiman, Field F. Willingham, Steven Keilin, Georgios I. Papachristou, Amitabh Chak, Adam Slivka, Daniel Mullady, Vladimir Kushnir, James Buxbaum, Rajesh N. Keswani, Timothy B. Gardner, Nauzer Forbes, Amit Rastogi, Andrew S. Ross, Joanna K. Law, Patrick Yachimski, Yen‐I Chen, Alan Barkun, Zachary L. Smith, Bret T. Petersen, Andrew Y. Wang, John R. Saltzman, Rebecca L. Spitzer, Collins Ordiah, Cathie Spino, Valerie Durkalski‐Mauldin, Peter Higgins, E Förster, Robert A. Moran, Brian Brauer, Erik Wamsteker, Qiang Cai, Emad Qayed, Royce Groce, Somashekar G. Krishna, Ashley L. Faulx, Brooke Glessing, Mordechai Rabinovitz, Gabriel Lang, Srinadh Komanduri, Jefferey Adler, Stuart R. Gordon, Rachid Mohamed, Mojtaba Olyaee, April Wood-Williams, Emily K. Depue Brewbaker, Andre Thornhill, Mariana Gould, Kristen Clasen, Jama Olsen, Violette C. Simon, Ayesha Kamal, Sarah Volk, Ambreen A. Merchant, Ali Lahooti, Nancy Furey, Gülsüm Anderson, Thomas Hollander, Alejandro Vázquez, Thomas Li, Steven M. Hadley, Millie Chau, Robinson Mendoza, Tida Tangwongchai, Casey L. Koza, Olivia Geraci, Lizbeth Núñez, Alexander M. Waters

Bibliographic record

VenueThe Lancet · 2024
Typearticle
Languageen
FieldMedicine
TopicGallbladder and Bile Duct Disorders
Canadian institutionsMcGill UniversityUniversity of Calgary
FundersNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institutes of Health
KeywordsMedicinePancreatitisStentBiliary stentRandomized controlled trialSurgery

Abstract

fetched live from OpenAlex

BACKGROUND: The combination of rectally administered indomethacin and placement of a prophylactic pancreatic stent is recommended to prevent pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP) in high-risk patients. Preliminary evidence suggests that the use of indomethacin might eliminate or substantially reduce the need for stent placement, a technically complex, costly, and potentially harmful intervention. METHODS: In this randomised, non-inferiority trial conducted at 20 referral centres in the USA and Canada, patients (aged ≥18 years) at high risk for post-ERCP pancreatitis were randomly assigned (1:1) to receive rectal indomethacin alone or the combination of indomethacin plus a prophylactic pancreatic stent. Patients, treating clinicians, and outcomes assessors were masked to study group assignment. The primary outcome was post-ERCP pancreatitis. To declare non-inferiority, the upper bound of the two-sided 95% CI for the difference in post-ERCP pancreatitis (indomethacin alone minus indomethacin plus stent) would have to be less than 5% (non-inferiority margin) in both the intention-to-treat and per-protocol populations. This trial is registered with ClinicalTrials.gov (NCT02476279), and is complete. FINDINGS: Between Sept 17, 2015, and Jan 25, 2023, a total of 1950 patients were randomly assigned. Post-ERCP pancreatitis occurred in 145 (14·9%) of 975 patients in the indomethacin alone group and in 110 (11·3%) of 975 in the indomethacin plus stent group (risk difference 3·6%; 95% CI 0·6-6·6; p=0·18 for non-inferiority). A post-hoc intention-to-treat analysis of the risk difference between groups showed that indomethacin alone was inferior to the combination of indomethacin plus prophylactic stent (p=0·011). The relative benefit of stent placement was generally consistent across study subgroups but appeared more prominent among patients at highest risk for pancreatitis. Safety outcomes (serious adverse events, intensive care unit admission, and hospital length of stay) did not differ between groups. INTERPRETATION: For preventing post-ERCP pancreatitis in high-risk patients, a strategy of indomethacin alone was not as effective as a strategy of indomethacin plus prophylactic pancreatic stent placement. These results support prophylactic pancreatic stent placement in addition to rectal indomethacin administration in high-risk patients, in accordance with clinical practice guidelines. FUNDING: US National Institutes of Health.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.005
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.011
Threshold uncertainty score0.038

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0030.005
Meta-epidemiology (narrow)0.0030.001
Meta-epidemiology (broad)0.0060.005
Bibliometrics0.0010.001
Science and technology studies0.0010.003
Scholarly communication0.0020.002
Open science0.0020.001
Research integrity0.0040.004
Insufficient payload (model declined to judge)0.0110.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.022
GPT teacher head0.297
Teacher spread0.275 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designRandomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations106
Published2024
Admission routes1
Has abstractno

Explore more

Same venueThe LancetSame topicGallbladder and Bile Duct DisordersFrench-language works237,207